Back

리메드 KOSDAQ

302550

Suggest a tag

Watch

Notes Naver Finance

Share buybacks

Trust In progress

D-91

Progress

22.17%

Total purchase commitment 10 × 100M KRW (1.4% of market cap)

Executed total 2.2 × 100M KRW (75,000 shares)

Purchase period 2026-08-04 ~ 2027-02-03

Contracted institution 신한투자증권 DART

Daily orders and executions

Meeting voting results

Annual 2026.03.26

Participation 52.1% Minority 26.4% Max. opposition 0.0% DART

1-1 제 23기 별도 재무제표 승인의 건 Approved Approval 100.0%
1-2 제 23기 연결 재무제표 승인의 건 Approved Approval 100.0%
2 정관일부 변경 승인의 건 Approved Approval 100.0%
3-1 이상식 기타비상무이사 선임의 건 Approved Approval 100.0%
3-2 장석호 기타비상무이사 선임의 건 Approved Approval 100.0%
3-3 김민영 독립이사 선임의 건 Approved Approval 100.0%
4 임원보수 지급규정 제정 승인의 건 Approved Approval 100.0%
5 주식매수선택권 부여 승인의 건 Approved Approval 100.0%

Previous meeting results

Financial indicators

Market cap

718 × 100M KRW

Approx. 691 × 100M KRW excluding treasury shares

PBR

1.84

PER

35.9

ROE

1.31%

Dividend yield

Debt-to-equity ratio

36.6%

Share price history

Share price

Daily close

Latest close

5-year high

5-year low

Use the period buttons above to adjust the range.

Shareholder distribution

Based on 2026 Semiannual report (2026-06-30)

Controlling shareholders total

35.70%

Minority shareholders (excl. related parties)

49.22%

Large outside holders (1%+)

11.35% (13 people)

Treasury shares

3.73%

Total shareholders

5,707 people

Annual earnings Trend

Financial statements

Consolidated · includes subsidiaries

리메드 — Annual Consolidated Financial statements
Item	2019	2020	2021	2022	2023	2024	2025
Income statement
Revenue	185.5 × 100M KRW	166.3 × 100M KRW	202 × 100M KRW	213.6 × 100M KRW	185.4 × 100M KRW	255.5 × 100M KRW	245 × 100M KRW
Operating profit	42.9 × 100M KRW	16.8 × 100M KRW	11.2 × 100M KRW	16.6 × 100M KRW	-28.6 × 100M KRW	11.2 × 100M KRW	7.3 × 100M KRW
Net income	43.6 × 100M KRW	-18.3 × 100M KRW	7.5 × 100M KRW	39.5 × 100M KRW	3.2 × 100M KRW	73.8 × 100M KRW	-3,547 × 10,000 KRW
Operating margin	23.11%	10.12%	5.56%	7.78%	-15.43%	4.39%	2.96%
Balance sheet
Total assets	349.5 × 100M KRW	734.7 × 100M KRW	772 × 100M KRW	781.3 × 100M KRW	550.6 × 100M KRW	590.6 × 100M KRW	539.1 × 100M KRW
Total liabilities	103.2 × 100M KRW	486.8 × 100M KRW	511 × 100M KRW	481.2 × 100M KRW	242.7 × 100M KRW	187.9 × 100M KRW	144.5 × 100M KRW
Total equity	246.2 × 100M KRW	247.9 × 100M KRW	261 × 100M KRW	300 × 100M KRW	307.9 × 100M KRW	402.7 × 100M KRW	394.6 × 100M KRW
Cash flow statement
Operating cash flow	-	-	-	-	-	12.4 × 100M KRW	24 × 100M KRW
Investing cash flow	-	-	-	-	-	64.7 × 100M KRW	45.8 × 100M KRW
Financing cash flow	-	-	-	-	-	-67.9 × 100M KRW	-41.7 × 100M KRW
Investment indicators
ROE	17.72%	-7.40%	2.88%	13.17%	1.04%	18.33%	-0.09%
Debt-to-equity ratio	41.92%	196.39%	195.80%	160.40%	78.80%	46.67%	36.60%
Separate total assets	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-
PER	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-
Detailed accounts
Current assets	-	-	491.9 × 100M KRW	-	-	286.5 × 100M KRW	277.8 × 100M KRW
Non-current assets	-	-	280.1 × 100M KRW	-	-	304.1 × 100M KRW	261.3 × 100M KRW
Current liabilities	-	-	55.3 × 100M KRW	-	-	90.4 × 100M KRW	94.7 × 100M KRW
Non-current liabilities	-	-	455.7 × 100M KRW	-	-	97.6 × 100M KRW	49.7 × 100M KRW
Equity attributable to owners	-	-	-	-	-	402.5 × 100M KRW	400.7 × 100M KRW
Share capital	-	-	30.6 × 100M KRW	-	-	30.6 × 100M KRW	31.5 × 100M KRW
Capital surplus	-	-	-	-	-	275.2 × 100M KRW	288.7 × 100M KRW
Other equity	-	-	-	-	-	4.2 × 100M KRW	-16.6 × 100M KRW
Accumulated other comprehensive income	-	-	-	-	-	-2.1 × 100M KRW	-2.2 × 100M KRW
Retained earnings	-	-	-24.4 × 100M KRW	-	-	94.5 × 100M KRW	99.3 × 100M KRW
Non-controlling interests	-	-	-	-	-	2,169 × 10,000 KRW	-6 × 100M KRW

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

리메드 — Quarterly Consolidated Financial statements
Item	24/3	24/6	24/9	24/12	25/3	25/6	25/9	25/12	26/3	26/6
Income statement
Revenue	53.2 × 100M KRW	77.6 × 100M KRW	60.3 × 100M KRW	64.5 × 100M KRW	64.4 × 100M KRW	55.5 × 100M KRW	58.1 × 100M KRW	67 × 100M KRW	71.8 × 100M KRW	73.7 × 100M KRW
Operating profit	-1.8 × 100M KRW	14.3 × 100M KRW	1.2 × 100M KRW	-2.5 × 100M KRW	3.8 × 100M KRW	2,490 × 10,000 KRW	2.7 × 100M KRW	5,135 × 10,000 KRW	6.8 × 100M KRW	9.5 × 100M KRW
Net income	-1.5 × 100M KRW	9.7 × 100M KRW	34.4 × 100M KRW	31.1 × 100M KRW	2.2 × 100M KRW	-2.2 × 100M KRW	1.7 × 100M KRW	-2 × 100M KRW	10.2 × 100M KRW	2.7 × 100M KRW
Operating margin	-3.48%	18.46%	2.06%	-3.88%	5.85%	0.45%	4.69%	0.77%	9.53%	12.83%
Balance sheet
Total assets	615.9 × 100M KRW	625 × 100M KRW	653.2 × 100M KRW	590.6 × 100M KRW	569.1 × 100M KRW	544.6 × 100M KRW	553.2 × 100M KRW	539.1 × 100M KRW	547.4 × 100M KRW	537.9 × 100M KRW
Total liabilities	312.5 × 100M KRW	286.9 × 100M KRW	278 × 100M KRW	187.9 × 100M KRW	163.8 × 100M KRW	137.7 × 100M KRW	153.8 × 100M KRW	144.5 × 100M KRW	155 × 100M KRW	166.2 × 100M KRW
Total equity	303.4 × 100M KRW	338.1 × 100M KRW	375.3 × 100M KRW	402.7 × 100M KRW	405.3 × 100M KRW	406.9 × 100M KRW	399.4 × 100M KRW	394.6 × 100M KRW	392.4 × 100M KRW	371.7 × 100M KRW
Cash flow statement
Operating cash flow	2.5 × 100M KRW	16.8 × 100M KRW	35.8 × 100M KRW	-42.6 × 100M KRW	11.3 × 100M KRW	5.4 × 100M KRW	-2.8 × 100M KRW	10.1 × 100M KRW	2.4 × 100M KRW	17.4 × 100M KRW
Investing cash flow	-48.8 × 100M KRW	3,803 × 10,000 KRW	15.3 × 100M KRW	97.8 × 100M KRW	3,393 × 10,000 KRW	23.2 × 100M KRW	8.1 × 100M KRW	14.2 × 100M KRW	22.8 × 100M KRW	-9.3 × 100M KRW
Financing cash flow	47.2 × 100M KRW	-15.5 × 100M KRW	-26.5 × 100M KRW	-73.2 × 100M KRW	-21.9 × 100M KRW	-14.5 × 100M KRW	5.7 × 100M KRW	-11.1 × 100M KRW	-9.1 × 100M KRW	-19.3 × 100M KRW
Investment indicators
Debt-to-equity ratio	103.00%	84.87%	74.08%	46.67%	40.43%	33.85%	38.50%	36.60%	39.51%	44.71%
EPS	-	-	-	-	-	-	-	-	-	-
Detailed accounts
Current assets	290 × 100M KRW	308.9 × 100M KRW	324 × 100M KRW	286.5 × 100M KRW	312.5 × 100M KRW	291.3 × 100M KRW	301.4 × 100M KRW	277.8 × 100M KRW	288.4 × 100M KRW	265.8 × 100M KRW
Non-current assets	326 × 100M KRW	316.1 × 100M KRW	329.3 × 100M KRW	304.1 × 100M KRW	256.6 × 100M KRW	253.3 × 100M KRW	251.8 × 100M KRW	261.3 × 100M KRW	259 × 100M KRW	272.1 × 100M KRW
Current liabilities	186.5 × 100M KRW	170.5 × 100M KRW	178.1 × 100M KRW	90.4 × 100M KRW	141.1 × 100M KRW	113.1 × 100M KRW	103 × 100M KRW	94.7 × 100M KRW	105 × 100M KRW	113.7 × 100M KRW
Non-current liabilities	126.1 × 100M KRW	116.4 × 100M KRW	99.9 × 100M KRW	97.6 × 100M KRW	22.7 × 100M KRW	24.6 × 100M KRW	50.8 × 100M KRW	49.7 × 100M KRW	50.1 × 100M KRW	52.5 × 100M KRW
Equity attributable to owners	306.3 × 100M KRW	341.8 × 100M KRW	380.8 × 100M KRW	402.5 × 100M KRW	407.4 × 100M KRW	409.5 × 100M KRW	405.4 × 100M KRW	400.7 × 100M KRW	399.4 × 100M KRW	383 × 100M KRW
Share capital	30.6 × 100M KRW	30.6 × 100M KRW	30.6 × 100M KRW	30.6 × 100M KRW	30.6 × 100M KRW	31.5 × 100M KRW	31.5 × 100M KRW	31.5 × 100M KRW	31.5 × 100M KRW	31.5 × 100M KRW
Capital surplus	251.5 × 100M KRW	275.2 × 100M KRW	276.5 × 100M KRW	275.2 × 100M KRW	275.2 × 100M KRW	292.8 × 100M KRW	290.9 × 100M KRW	288.7 × 100M KRW	288.7 × 100M KRW	288.7 × 100M KRW
Other equity	4.2 × 100M KRW	4.2 × 100M KRW	4.2 × 100M KRW	4.2 × 100M KRW	4.2 × 100M KRW	-9 × 100M KRW	-15.7 × 100M KRW	-16.6 × 100M KRW	-9.1 × 100M KRW	-31.4 × 100M KRW
Accumulated other comprehensive income	-2.4 × 100M KRW	-1.8 × 100M KRW	-4,462 × 10,000 KRW	-2.1 × 100M KRW	-1.7 × 100M KRW	-2.2 × 100M KRW	-2.2 × 100M KRW	-2.2 × 100M KRW	-2.1 × 100M KRW	-2.1 × 100M KRW
Retained earnings	22.4 × 100M KRW	33.5 × 100M KRW	69.9 × 100M KRW	94.5 × 100M KRW	99 × 100M KRW	96.5 × 100M KRW	100.9 × 100M KRW	99.3 × 100M KRW	90.4 × 100M KRW	96.3 × 100M KRW
Non-controlling interests	-2.8 × 100M KRW	-3.7 × 100M KRW	-5.6 × 100M KRW	2,169 × 10,000 KRW	-2.2 × 100M KRW	-2.7 × 100M KRW	-6 × 100M KRW	-6 × 100M KRW	-7 × 100M KRW	-11.3 × 100M KRW

Income figures cover the quarter, not the year to date. Balance sheet figures are quarter-end balances.

Quarterly cash flow is calculated from changes in cumulative totals.

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

Separate · this company only

리메드 — Annual Separate Financial statements
Item	2019	2020	2021	2022	2023	2024	2025
Income statement
Revenue	185.5 × 100M KRW	166.3 × 100M KRW	202 × 100M KRW	213.2 × 100M KRW	179.7 × 100M KRW	246.7 × 100M KRW	233.4 × 100M KRW
Operating profit	42.9 × 100M KRW	17.9 × 100M KRW	18.3 × 100M KRW	22.9 × 100M KRW	-9.6 × 100M KRW	32.2 × 100M KRW	30.5 × 100M KRW
Net income	43.6 × 100M KRW	-16.4 × 100M KRW	15.3 × 100M KRW	47.5 × 100M KRW	25 × 100M KRW	60.7 × 100M KRW	19.4 × 100M KRW
Operating margin	23.11%	10.78%	9.05%	10.74%	-5.33%	13.05%	13.05%
Balance sheet
Total assets	349.5 × 100M KRW	735.7 × 100M KRW	780.2 × 100M KRW	793.5 × 100M KRW	543.9 × 100M KRW	574 × 100M KRW	541 × 100M KRW
Total liabilities	103.2 × 100M KRW	485.8 × 100M KRW	509.5 × 100M KRW	479.4 × 100M KRW	203.6 × 100M KRW	149.7 × 100M KRW	104.8 × 100M KRW
Total equity	246.2 × 100M KRW	249.9 × 100M KRW	270.8 × 100M KRW	314 × 100M KRW	340.3 × 100M KRW	424.3 × 100M KRW	436.2 × 100M KRW
Cash flow statement
Operating cash flow	-	-	-	-	-	27.2 × 100M KRW	39.2 × 100M KRW
Investing cash flow	-	-	-	-	-	32.8 × 100M KRW	41.4 × 100M KRW
Financing cash flow	-	-	-	-	-	-64.3 × 100M KRW	-41.4 × 100M KRW
Investment indicators
ROE	17.72%	-6.54%	5.66%	15.12%	7.34%	14.31%	4.45%
Debt-to-equity ratio	41.92%	194.45%	188.15%	152.68%	59.83%	35.29%	24.03%
Separate total assets	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-
PER	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-
Detailed accounts
Current assets	-	-	489.6 × 100M KRW	-	-	259.8 × 100M KRW	269.3 × 100M KRW
Non-current assets	-	-	290.6 × 100M KRW	-	-	314.2 × 100M KRW	271.7 × 100M KRW
Current liabilities	-	-	54.2 × 100M KRW	-	-	57.8 × 100M KRW	61.1 × 100M KRW
Non-current liabilities	-	-	455.2 × 100M KRW	-	-	91.9 × 100M KRW	43.7 × 100M KRW
Share capital	-	-	30.6 × 100M KRW	-	-	30.6 × 100M KRW	31.5 × 100M KRW
Capital surplus	-	-	-	-	-	275.2 × 100M KRW	288.3 × 100M KRW
Other equity	-	-	-	-	-	4.2 × 100M KRW	-16.6 × 100M KRW
Accumulated other comprehensive income	-	-	-	-	-	-2.2 × 100M KRW	-2.3 × 100M KRW
Retained earnings	-	-	-14.6 × 100M KRW	-	-	116.4 × 100M KRW	135.3 × 100M KRW

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

리메드 — Quarterly Separate Financial statements
Item	24/3	24/6	24/9	24/12	25/3	25/6	25/9	25/12	26/3	26/6
Income statement
Revenue	-	-	-	-	-	-	-	-	67 × 100M KRW	70.7 × 100M KRW
Operating profit	-	-	-	-	-	-	-	-	9.1 × 100M KRW	13 × 100M KRW
Net income	-	-	-	-	-	-	-	-	13.3 × 100M KRW	14.2 × 100M KRW
Operating margin	-	-	-	-	-	-	-	-	13.54%	18.41%
Balance sheet
Total assets	-	-	-	-	-	-	-	-	547.8 × 100M KRW	545.6 × 100M KRW
Total liabilities	-	-	-	-	-	-	-	-	110.8 × 100M KRW	117.8 × 100M KRW
Total equity	-	-	-	-	-	-	-	-	437 × 100M KRW	427.8 × 100M KRW
Cash flow statement
Operating cash flow	-	-	-	-	-	-	-	-	7.2 × 100M KRW	19.2 × 100M KRW
Investing cash flow	-	-	-	-	-	-	-	-	22.1 × 100M KRW	-9.4 × 100M KRW
Financing cash flow	-	-	-	-	-	-	-	-	-12.6 × 100M KRW	-19.4 × 100M KRW
Investment indicators
Debt-to-equity ratio	-	-	-	-	-	-	-	-	25.36%	27.54%
EPS	-	-	-	-	-	-	-	-	-	-
Detailed accounts
Current assets	-	-	-	259.8 × 100M KRW	-	-	-	269.3 × 100M KRW	278 × 100M KRW	256.9 × 100M KRW
Non-current assets	-	-	-	314.2 × 100M KRW	-	-	-	271.7 × 100M KRW	269.8 × 100M KRW	288.7 × 100M KRW
Current liabilities	-	-	-	57.8 × 100M KRW	-	-	-	61.1 × 100M KRW	66.6 × 100M KRW	71.2 × 100M KRW
Non-current liabilities	-	-	-	91.9 × 100M KRW	-	-	-	43.7 × 100M KRW	44.3 × 100M KRW	46.6 × 100M KRW
Share capital	-	-	-	30.6 × 100M KRW	-	-	-	31.5 × 100M KRW	31.5 × 100M KRW	31.5 × 100M KRW
Capital surplus	-	-	-	275.2 × 100M KRW	-	-	-	288.3 × 100M KRW	288.3 × 100M KRW	288.3 × 100M KRW
Other equity	-	-	-	4.2 × 100M KRW	-	-	-	-16.6 × 100M KRW	-9.1 × 100M KRW	-31.4 × 100M KRW
Accumulated other comprehensive income	-	-	-	-2.2 × 100M KRW	-	-	-	-2.3 × 100M KRW	-2.3 × 100M KRW	-2.3 × 100M KRW
Retained earnings	-	-	-	116.4 × 100M KRW	-	-	-	135.3 × 100M KRW	128.6 × 100M KRW	141.7 × 100M KRW

Income figures cover the quarter, not the year to date. Balance sheet figures are quarter-end balances.

Quarterly cash flow is calculated from changes in cumulative totals.

ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.

Legacy summaries and estimates; may include data with unverified accounting scope.

리메드 — Annual Legacy summary & estimates Financial statements
Item	2017	2018	2019	2020	2021	2022	2023 Consolidated	2024 Consolidated	2025 Consolidated
Income statement
Revenue	62.4 × 100M KRW	80 × 100M KRW	185.5 × 100M KRW	166.3 × 100M KRW	202 × 100M KRW	213.6 × 100M KRW	185.4 × 100M KRW	255.5 × 100M KRW	245 × 100M KRW
Operating profit	3.2 × 100M KRW	-8.4 × 100M KRW	42.9 × 100M KRW	16.8 × 100M KRW	11.2 × 100M KRW	16.6 × 100M KRW	-28.6 × 100M KRW	11.2 × 100M KRW	7.3 × 100M KRW
Net income	3,624 × 10,000 KRW	-73.8 × 100M KRW	43.6 × 100M KRW	-18.3 × 100M KRW	7.5 × 100M KRW	39.5 × 100M KRW	3.2 × 100M KRW	73.8 × 100M KRW	-3,547 × 10,000 KRW
Operating margin	5.20%	-10.45%	23.11%	10.12%	5.56%	7.78%	-15.43%	4.39%	2.96%
Balance sheet
Total assets	-	-	-	-	-	-	550.6 × 100M KRW	590.6 × 100M KRW	539.1 × 100M KRW
Total liabilities	84.1 × 100M KRW	105.7 × 100M KRW	103.2 × 100M KRW	486.8 × 100M KRW	511 × 100M KRW	481.2 × 100M KRW	242.7 × 100M KRW	187.9 × 100M KRW	144.5 × 100M KRW
Total equity	41.9 × 100M KRW	109.4 × 100M KRW	246.2 × 100M KRW	247.9 × 100M KRW	261 × 100M KRW	300 × 100M KRW	307.9 × 100M KRW	402.7 × 100M KRW	394.6 × 100M KRW
Investment indicators
ROE	0.87%	-67.44%	17.72%	-7.40%	2.88%	13.17%	1.04%	18.33%	-0.09%
Debt-to-equity ratio	200.90%	96.55%	41.92%	196.39%	195.80%	160.40%	78.80%	46.67%	36.60%
Separate total assets	-	-	-	-	-	-	543.9 × 100M KRW	574 × 100M KRW	541 × 100M KRW
EPS	-	-	-	-	-	KRW 131	KRW 26	KRW 234	KRW 17
PER	-	-	-	-	-	18.92×	125.10×	15.38×	181.84×
PBR	-	-	-	-	-	2.53	3.24	2.74	2.37
Dividend per share	-	-	-	-	-	-	-	-	-

리메드 — Quarterly Legacy summary & estimates Financial statements
Item	24/3 Consolidated	24/6 Consolidated	24/9 Consolidated	24/12 Consolidated	25/3 Consolidated	25/6 Consolidated	25/9 Consolidated	25/12 Consolidated	26/3 Consolidated	26/6 Consolidated
Income statement
Revenue	53.2 × 100M KRW	77.6 × 100M KRW	60.3 × 100M KRW	64.5 × 100M KRW	64.4 × 100M KRW	55.5 × 100M KRW	58.1 × 100M KRW	67 × 100M KRW	71.8 × 100M KRW	73.7 × 100M KRW
Operating profit	-1.8 × 100M KRW	14.3 × 100M KRW	1.2 × 100M KRW	-2.5 × 100M KRW	3.8 × 100M KRW	2,490 × 10,000 KRW	2.7 × 100M KRW	5,135 × 10,000 KRW	6.8 × 100M KRW	9.5 × 100M KRW
Net income	-1.5 × 100M KRW	9.7 × 100M KRW	34.4 × 100M KRW	31.1 × 100M KRW	2.2 × 100M KRW	-2.2 × 100M KRW	1.7 × 100M KRW	-2 × 100M KRW	10.2 × 100M KRW	2.7 × 100M KRW
Operating margin	-3.48%	18.46%	2.06%	-3.88%	5.85%	0.45%	4.69%	0.77%	9.53%	12.83%
Balance sheet
Total assets	615.9 × 100M KRW	625 × 100M KRW	653.2 × 100M KRW	590.6 × 100M KRW	569.1 × 100M KRW	544.6 × 100M KRW	553.2 × 100M KRW	539.1 × 100M KRW	547.4 × 100M KRW	537.9 × 100M KRW
Total liabilities	312.5 × 100M KRW	286.9 × 100M KRW	278 × 100M KRW	187.9 × 100M KRW	163.8 × 100M KRW	137.7 × 100M KRW	153.8 × 100M KRW	144.5 × 100M KRW	155 × 100M KRW	166.2 × 100M KRW
Total equity	303.4 × 100M KRW	338.1 × 100M KRW	375.3 × 100M KRW	402.7 × 100M KRW	405.3 × 100M KRW	406.9 × 100M KRW	399.4 × 100M KRW	394.6 × 100M KRW	392.4 × 100M KRW	371.7 × 100M KRW
Investment indicators
Debt-to-equity ratio	103.00%	84.87%	74.08%	46.67%	40.43%	33.85%	38.50%	36.60%	39.51%	44.71%
EPS	-	-	-	-	-	-	-	-	-	-

Income figures cover the quarter, not the year to date. Balance sheet figures are quarter-end balances.

Property holdings

Total book value

208 × 100M KRW

Total assessed land value

Ratio to market cap

29.0%

Land

4 records

Buildings

4 records

Category	Location	Use	Area	Book value	Assessed land value
Land Unverified	성남시 수정구 창곡동	사옥부지	-	77 × 100M KRW	-
Building Unverified	성남시 수정구 창곡동	사옥	-	62 × 100M KRW	-
Building Unverified	충청북도 청주시 흥덕구 오송읍 오송생명2로 84	오송 사업장	-	36 × 100M KRW	-
Land Unverified	충청북도 청주시 흥덕구 오송읍 오송생명2로 84	공장부지	-	34 × 100M KRW	-
Land Unverified	대전광역시 유성구 테크노2로 187	대전 사업장	-	-	-
Building Unverified	대전광역시 유성구 테크노2로 187	대전 사업장	-	-	-
Land Unverified	성남시 분당구 삼평동	-	-	-	-
Building Unverified	성남시 분당구 삼평동	-	-	-	-

Ownership structure

Is a listed company shown as unlisted?

Corporate shareholders

Corporate and institutional holders identified in collected disclosures. This is not a complete shareholder register. Reporting-group holdings may overlap with individual holdings.

Business report analysis

Analysis date 2026.05.25 23:46 | Based on 2025 Annual report

Unverified Original business report

사업 개요

리메드는 신경세포의 탈분극을 유도하는 비침습적 방법으로 각종 질환을 치료·재활하는 의료기기를 개발, 제조, 판매하는 회사입니다.
주요 사업은 뇌질환 치료·재활 목적의 뇌재활 사업, 신경자기자극을 활용한 만성통증치료 사업, 에스테틱 사업입니다.

주요 매출원

2025년 제품 판매실적 합계는 약 233억원입니다.
만성통증치료(PMS): 약 138억원 (전체 매출의 약 59.1%)
뇌재활(TMS): 약 39억원 (약 16.8%)
기타(etc): 약 29억원 (약 12.3%)
상품: 약 14억원 (약 6.0%)
에스테틱(Aes): 약 13억원 (약 5.8%)
2025년 지역별 매출은 국내 약 66억원, 해외 약 167억원으로 해외 매출 비중이 약 71.7%입니다.

원가 구조 / 비용 특성

제23기 매출액은 약 245억원, 매출원가는 약 104억원, 매출총이익은 약 141억원입니다.
제23기 영업이익은 약 7억원으로, 전기 약 11억원 대비 감소했습니다. 당기순손실은 약 0.4억원입니다.

자회사

(주)리메드브레인스팀: 재택 치료 사업 진출을 위한 자회사로, 리메드가 80.5% 지분을 보유하고 있습니다.
REMED JAPAN CO., LTD: 일본 시장 사업 진출을 위한 JV로, 리메드가 100.0% 지분을 보유하고 있습니다.
(주)플레이투큐어: 디지털치료제 개발을 위한 자회사로, 리메드가 44.3% 지분을 보유하고 있습니다.
(주)이지렉스: 리메드가 16.1% 지분을 보유한 계열회사입니다.

차입 구조

주요채권자 표는 해당사항 없음으로 기재되어 있으나, 별도 표에 전환사채 당기말 약 23억원, 파생상품부채 약 8억원, 합계 약 32억원이 기재되어 있습니다.

Employees

114 people

Subsidiaries

4 items

Material subsequent events

해당사항 없음.

Articles of incorporation analysis

Analysis date 2026.06.19 13:25 | Last amended 2025.03.26

Unverified Original articles of incorporation

주주친화

분기배당: 이사회 결의로 3월·6월·9월 말일 기준 주주에게 분기배당을 할 수 있음 (제55조)

주주비친화

집중투표제 명시적 배제: 2인 이상 이사 선임 시 상법 제382조의2의 집중투표제를 적용하지 않아 소수주주의 이사 선임 가능성을 제한함 (제33조③)
이사회 결의만으로 1,000억원 전환사채 제3자 배정: 주주 외의 자에게 전환사채를 발행할 수 있어 경영권 분쟁 시 우호지분 확보 수단이 될 수 있음 (제17조①)
이사회 결의만으로 1,000억원 신주인수권부사채 제3자 배정: 주주 외의 자에게 신주인수권부사채를 발행할 수 있어 기존 주주의 지분 희석 위험이 있음 (제18조①)
이사 임기 3년 고정: 상법상 최장 수준의 임기를 정해 이사회 교체 속도를 늦출 수 있음 (제34조①)

기타 주목 조항

이사회 의장 선임: 이사회 의장은 이사회 결의로 선임하지만 대표집행임원 배제 요건은 없음 (제37조의2)
감사 정원: 회사는 1인 이상 2인 이내의 감사를 둘 수 있음 (제44조)
배당 기준일: 이익배당은 매 결산기말 현재 주주명부상 주주 또는 질권자에게 지급함 (제54조③)

Board of directors

Number of directors

3–10 people

Director term

3 years (Fixed)

Remaining term for replacements

Staggered board

None

Cumulative voting

Separate chair and CEO

Gender diversity requirement

Auditors

Number of auditors

1–2 people

Auditor term

3 years (Fixed)

Shareholder meetings and dividends

Meeting notice period

14 days

Written voting

Electronic voting

Dividend record date

매 결산기말

Third-party allotment limit by board resolution alone

Convertible bonds (CB)

1,000 × 100M KRW

Bonds with warrants (BW)

1,000 × 100M KRW

Compensation basis

Director: 이사의 보수는 주주총회의 결의로 정한다.
Auditors: 감사의 보수와 퇴직금은 이사의 보수와 퇴직금 규정을 준용하되, 감사 보수 의안은 이사 보수 의안과 구분하여 상정·의결한다.
Retirement payments: 이사의 퇴직금은 주주총회 결의를 거친 임원퇴직금지급규정에 의한다.

Executive compensation

Based on 2025 Annual report

Total compensation

7 × 100M KRW

Executives

7 people

Average per executive

9,394 × 10,000 KRW

Total dividends

Compensation / dividends

No dividend

Controlling shareholders

Name	Relationship	Age	Ownership
이근용	최대주주 본인	Age 58	25.70%
홍성필	임원	Age 58	6.00%
이상용	최대주주의 친인척	-	3.20%
류승권	임원	Age 60	0.00%

Holders of 5% or more

Holder	Holding ratio	Shares held	Change in ownership	Reason for filing	Report type	Filing date
이근용	36.88%	11,166,576	+0.75%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-08-20
이근용	36.13%	11,166,476	+0.01%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-07-30
이근용	36.12%	11,166,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-06-24
이근용	36.12%	11,166,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-06-10
이근용	36.12%	11,166,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-05-28
이근용	36.12%	11,166,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-05-04
이근용	36.12%	11,166,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-04-29
이근용	36.12%	11,166,076	+0.01%	특별관계자 변동 및 장내매수	일반	2026-04-10
이근용	36.11%	11,162,776	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-04-03
이근용	36.11%	11,162,776	+0.22%	보고자 및 특별관계자의 주식담보대출 변경 및 특별관계자 변동	일반	2026-03-27
이근용	35.89%	11,092,776	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-03-19
이근용	35.89%	11,092,776	+0.67%	보고자 및 특별관계자의 주식담보대출 변경	일반	2026-03-12
이근용	35.22%	11,092,776	+0.01%	보고자 및 특별관계자의 주식담보대출 변경 특별관계자 변동 및 장내매수	일반	2026-02-26
이근용	35.21%	11,088,976	+0.01%	보고자 및 특별관계자의 주식담보대출 변경 특별관계자 변동 및 장내매수	일반	2026-02-03
이근용	35.20%	11,087,176	+0.01%	특별관계자 변동 및 장내매수	일반	2026-01-28
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-12-24
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-12-09
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-12-08
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-11-28
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-11-21
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-10-01
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-09-25
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-09-19
이근용	35.19%	11,084,076	0.00%	보고자 및 특별관계자의 주식담보대출 변경	일반	2025-09-15
삼성이노베이티브신기술사업투자조합제1호	4.75%	1,571,989	-1.66%	1% 이상 변동보고	약식	2025-09-03
이근용	35.19%	11,084,076	0.00%	보고자와 특별관계자의 주식담보대출 변경	일반	2025-08-27
이근용	35.19%	11,084,076	0.00%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-08-21
이근용	35.19%	11,084,076	0.00%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-08-11
삼성이노베이티브신기술사업투자조합제1호	6.41%	2,148,714	-1.05%	1% 이상 변동보고	약식	2025-07-22
이근용	35.19%	11,084,076	-0.32%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-06-27
삼성이노베이티브신기술사업투자조합제1호	7.46%	2,497,530	-1.07%	1% 이상 변동보고	약식	2025-06-20
이근용	35.51%	11,084,076	-0.33%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-06-12
이근용	35.84%	11,084,076	0.00%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-05-30
이근용	35.84%	11,084,076	-0.34%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-05-21
이근용	36.18%	11,084,076	-0.17%	특별관계자 및 특별관계자의 주식담보대출 변경	일반	2025-04-09
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2025-03-28
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2025-03-17
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2025-02-28
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2025-02-19
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2025-02-13
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-12-26
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-12-13
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-12-02
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-11-18
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-10-08
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-09-25
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-09-13
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-08-21
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-08-06
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-06-25
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-06-21
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-06-05
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-03-26
이근용	36.35%	11,135,000	0.00%	특별관계자의 주식담보대출 변경	일반	2024-03-06
삼성이노베이티브신기술사업투자조합제1호	8.53%	2,858,163	+8.53%	전환사채권 인수	약식	2024-02-29

Major shareholders

Major shareholders (3 people)

Based on 2025 Business report

Name	Shares owned	Ownership	Relationship
이근용	8,110,000	25.75%	Controlling shareholder
홍성필	1,890,000	6.00%	임원
이상용	1,000,000	3.18%	계열회사 임원

Auditors

Analysis date 2026.08.26 12:12

Auditor	Type	Term start	Term end	Tenure	D-day
홍기승	Auditor	-	2027.03.28	5 years	D-144

Executives

Name	Position	Category	Age	Term end
홍기승	감사	감사	Age 68	D-144
류승권	이사	Outside director	Age 60	D-508
이정수	본부장	집행임원	Age 60	D-57
김민영	이사	Outside director	Age 59	D-873
이근용	이사회 의장	대표집행임원	Age 58	D-234
이상식	이사	Other non-executive director	Age 58	D-873
홍성필	단장	집행임원	Age 58	D-57
김태군	본부장	집행임원	Age 54	D-57
장석호	이사	Other non-executive director	Age 53	D-873
신대현	본부장	집행임원	Age 52	D-57
이성온	이사	Outside director	Age 51	D-511
송종은	본부장	집행임원	Age 49	D-57

DART disclosures

Loading disclosures…

Activism & governance

Shareholder returns Importance 3 2026.10.21 10:30

리메드, 자사주 소각으로 신주 오버행 대응

리메드는 약 20억원 규모의 자기주식 소각을 결정했다. 기사는 주식 수 증가에 따른 기존 주주 지분가치 희석을 막기 위한 조치라고 전했다.

Shareholder perspective 자사주 소각은 신주 발행으로 인한 잠재적 희석 우려를 완화할 수 있는 주주환원 조치다. 관련 전환사채 결정도 있어 자본정책의 추이를 살펴볼 필요가 있다.

리메드 KOSDAQ

Share buybacks Collapse Share buybacks

Meeting voting results Collapse Meeting voting results

Financial indicators Collapse Financial indicators

Share price history 10 years 5 years 3 years 1 year 3 months 1 week Collapse Share price history

Shareholder distribution Collapse Shareholder distribution

Annual earnings Trend Collapse Annual earnings

Financial statements Collapse Financial statements

Consolidated

Separate

Legacy summary & estimates

Property holdings Collapse Property holdings

Ownership structure Collapse Ownership structure

Corporate shareholders Collapse Corporate shareholders

Business report analysis Collapse Business report analysis

사업 개요

주요 매출원

원가 구조 / 비용 특성

자회사

차입 구조

Articles of incorporation analysis Collapse Articles of incorporation analysis

주주친화

주주비친화

기타 주목 조항

Board of directors

Auditors

Shareholder meetings and dividends

Third-party allotment limit by board resolution alone

Compensation basis

Executive compensation Collapse Executive compensation

Controlling shareholders Collapse Controlling shareholders

Holders of 5% or more Collapse Holders of 5% or more

Major shareholders Collapse Major shareholders

Major shareholders (3 people)

Auditors Collapse Auditors

Executives Collapse Executives

DART disclosures Collapse DART disclosures

Activism & governance Collapse Activism & governance

리메드, 자사주 소각으로 신주 오버행 대응

Share buybacks

Meeting voting results

Financial indicators

Share price history

Shareholder distribution

Annual earnings Trend

Financial statements

Property holdings

Ownership structure

Corporate shareholders

Business report analysis

Articles of incorporation analysis

Executive compensation

Controlling shareholders

Holders of 5% or more

Major shareholders

Auditors

Executives

DART disclosures

Activism & governance